# Baptist Health IRB #1 – FDA Inspection, Feb 22, 2018

Source: https://www.keypedia.com/records/fda_inspections/baptist-health-irb-1/4ac90b6f-fd55-45da-abfe-25672c25cb36
Source feed: FDA_Inspections

> FDA inspection 1041815 of Baptist Health IRB #1, February 22, 2018. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 56. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1041815
- Company Name: Baptist Health IRB #1
- Inspection Date: 2018-02-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1219429 - 2023-09-28](https://www.keypedia.com/records/fda_inspections/baptist-health-irb-1/c1090dfa-dd72-4d0f-81a9-ae4c6c589f01)
- FDA Inspection 768288 - 2012-02-08

## Related Officers

- [Investigator](https://www.keypedia.com/people/donna-d-gallien/3b5d4a2b-4c8b-4618-a986-3a23c12faad4)

Company: https://www.keypedia.com/companies/baptist-health-irb-1/4c5a9c14-34fd-4899-812c-c7278bf89a75

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
